Myriad Genetics Inc (MYGN)

Capital Expenditure

-$16.30M

TTM · Period ending: · USD

MYGN logo

MYGN Capital Expenditure

Latest reported-$16.30M
MYGN TTM CapEx (-$5.80M → -$16.30M)
High-resolution chart · PNG

MYGN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-5,255,213
-5,188,110
-5,634,528
-5,098,346
-4,617,196
-4,054,000
-3,700,000
-3,900,000
-4,000,000
-4,500,000
-3,700,000
-3,500,000
-3,200,000
-2,800,000
-3,500,000
-3,800,000
-4,700,000
-5,000,000
-5,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.